VerImmune
Signal active
Organization
Contact Information
Overview
Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.
About
Industries
Biotechnology, Health Care, Therapeutics, Oncology
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VerImmune headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $311.1M in funding across 48 round(s). With a team of 11-50 employees, VerImmune is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - VerImmune, raised $3.1M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
4
Lead Investors
0
Total Funding Amount
$6.5M
Details
2
VerImmune has raised a total of $6.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 2.5M | ||
| 2023 | Seed | 3.1M |
Investors
VerImmune is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Fosun Pharma | - | FUNDING ROUND - Fosun Pharma | 3.1M |
| Haolin Sung | - | FUNDING ROUND - Haolin Sung | 3.1M |
| VerImmune | - | FUNDING ROUND - VerImmune | 3.1M |
| Proxima Ventures Ltd | - | FUNDING ROUND - Proxima Ventures Ltd | 3.1M |
Recent Activity
There is no recent news or activity for this profile.